<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28531227</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing.</ArticleTitle><Pagination><StartPage>e0177657</StartPage><MedlinePgn>e0177657</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0177657</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0177657</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) and Coxsackievirus A16 (CA16) remain the predominant pathogens in hand, foot, and mouth disease (HFMD), but the factors underlying the pathogenesis of EV71 and CA16 infections have not been elucidated. Recently, the functions of microRNAs (miRNAs) in pathogen-host interactions have been highlighted. In the present study, we performed comprehensive miRNA profiling in EV71- and CA16-infected human umbilical vein endothelial cells (HUVECs) at multiple time points using high-throughput sequencing. The results showed that 135 known miRNAs exhibited remarkable differences in expression. Of these, 30 differentially expressed miRNAs presented opposite trends in EV71- and CA16-infected samples. Subsequently, we mainly focused on the 30 key differentially expressed miRNAs through further screening to predict targets. Gene ontology (GO) and pathway analysis of the predicted targets showed the enrichment of 14 biological processes, 9 molecular functions, 8 cellular components, and 85 pathways. The regulatory networks of these miRNAs with predicted targets, GOs, pathways, and co-expression genes were determined, suggesting that miRNAs display intricate regulatory mechanisms during the infection phase. Consequently, we specifically analyzed the hierarchical GO categories of the predicted targets involved in biological adhesion. The results indicated that the distinct changes induced by EV71 and CA16 infection may be partly linked to the function of the blood-brain barrier. Taken together, this is the first report describing miRNA expression profiles in HUVECs with EV71 and CA16 infections using high-throughput sequencing. Our data provide useful insights that may help to elucidate the different host-pathogen interactions following EV71 and CA16 infection and offer novel therapeutic targets for these infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Huiwen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ning</LastName><ForeName>Ruotong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongzhe</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zening</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Haitao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Longding</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2623-5847</Identifier><AffiliationInfo><Affiliation>Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infections Disease, Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Kunming, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063990" MajorTopicYN="N">Gene Ontology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017423" MajorTopicYN="N">Sequence Analysis, RNA</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28531227</ArticleId><ArticleId IdType="pmc">PMC5439704</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0177657</ArticleId><ArticleId IdType="pii">PONE-D-17-05110</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Koh WM, Bogich T, Siegel K, Jin J, Chong EY, Tan CY, et al.
The Epidemiology of Hand, Foot and Mouth Disease in Asia: A Systematic Review and Analysis. Pediatr Infect Dis J. 2016; 35: e285&#x2013;300. doi: 10.1097/INF.0000000000001242
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001242</ArticleId><ArticleId IdType="pmc">PMC5130063</ArticleId><ArticleId IdType="pubmed">27273688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Q, He F, Kwang J. Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines. Viruses. 2015; 7: 6441&#x2013;6457. doi: 10.3390/v7122949
</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122949</ArticleId><ArticleId IdType="pmc">PMC4690872</ArticleId><ArticleId IdType="pubmed">26670245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, et al.
Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014; 10: 360&#x2013;367. doi: 10.4161/hv.27087
</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.27087</ArticleId><ArticleId IdType="pmc">PMC4185891</ArticleId><ArticleId IdType="pubmed">24231751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo D, Krogstad P. Enteroviruses in the early 21st century: new manifestations and challenges. Curr Opin Pediatr. 2016; 28: 107&#x2013;113. doi: 10.1097/MOP.0000000000000303
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000303</ArticleId><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP Jr., Kennett ML, Pallansch MA. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 1999; 73: 9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JJ, Seah JB, Chow VT, Poh CL, Tan EL. Comparative proteome analyses of host protein expression in response to Enterovirus 71 and Coxsackievirus A16 infections. J Proteomics. 2011; 74: 2018&#x2013;2024. doi: 10.1016/j.jprot.2011.05.022
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jprot.2011.05.022</ArticleId><ArticleId IdType="pubmed">21621020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Parker EP, Grassly NC. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr Opin Infect Dis. 2015; 28: 479&#x2013;487. doi: 10.1097/QCO.0000000000000187
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q, Wang Y, Bian L, Xu M, Liang Z. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerg Microbes Infect. 2016; 5: e75
doi: 10.1038/emi.2016.73
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.73</ArticleId><ArticleId IdType="pmc">PMC5141264</ArticleId><ArticleId IdType="pubmed">27436364</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Mao QY, Liang ZL, Ji H, Zhu FC. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines. 2014; 13: 609&#x2013;618. doi: 10.1586/14760584.2014.897617
</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2014.897617</ArticleId><ArticleId IdType="pubmed">24621093</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Liu L, Mo Z, Wang X, Xia J, Liang Z, et al.
An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014; 370: 829&#x2013;837. doi: 10.1056/NEJMoa1303224
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y, Ku Z, Liu Q, Leng Q, Huang Z. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine. 2014; 32: 2406&#x2013;2412. doi: 10.1016/j.vaccine.2014.03.012
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.03.012</ArticleId><ArticleId IdType="pubmed">24657161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zhang Y, Zhang X, Hu Y, Dong C, Liu L, et al.
Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques. Virology. 2017; 500: 198&#x2013;208. doi: 10.1016/j.virol.2016.10.031
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.10.031</ArticleId><ArticleId IdType="pubmed">27829175</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter J, Jung S, Keller S, Gregory RI, Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11: 228&#x2013;234. doi: 10.1038/ncb0309-228
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb0309-228</ArticleId><ArticleId IdType="pubmed">19255566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15: 509&#x2013;524. doi: 10.1038/nrm3838
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3838</ArticleId><ArticleId IdType="pubmed">25027649</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol. 2010; 10: 111&#x2013;122. doi: 10.1038/nri2708
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2708</ArticleId><ArticleId IdType="pubmed">20098459</ArticleId></ArticleIdList></Reference><Reference><Citation>Piva R, Spandidos DA, Gambari R. From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol. 2013; 43: 985&#x2013;994. doi: 10.3892/ijo.2013.2059
</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2013.2059</ArticleId><ArticleId IdType="pmc">PMC3829774</ArticleId><ArticleId IdType="pubmed">23939688</ArticleId></ArticleIdList></Reference><Reference><Citation>Louten J, Beach M, Palermino K, Weeks M, Holenstein G. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomark Insights. 2015; 10: 25&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718089</ArticleId><ArticleId IdType="pubmed">26819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh DW, Klimstra WB. MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends Mol Med. 2017; 23: 80&#x2013;93. doi: 10.1016/j.molmed.2016.11.003
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahamtan A, Inchley CS, Marzban M, Tavakoli-Yaraki M, Teymoori-Rad M, Nakstad B, et al.
The role of microRNAs in respiratory viral infection: friend or foe?
Rev Med Virol. 2016; 26: 389&#x2013;407. doi: 10.1002/rmv.1894
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.1894</ArticleId><ArticleId IdType="pmc">PMC7169129</ArticleId><ArticleId IdType="pubmed">27373545</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Song J, Liu L, Li J, Tang B, Zhang Y, et al.
Comparison analysis of microRNAs in response to EV71 and CA16 infection in human bronchial epithelial cells by high-throughput sequencing to reveal differential infective mechanisms. Virus Res. 2017; 228: 90&#x2013;101. doi: 10.1016/j.virusres.2016.11.024
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.11.024</ArticleId><ArticleId IdType="pubmed">27890633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Song J, Liu L, Li J, Tang B, Wang J, et al.
Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from high-throughput sequencing in rhesus monkey peripheral blood mononuclear cells. Int J Biochem Cell Biol. 2016; 81: 20&#x2013;31. doi: 10.1016/j.biocel.2016.10.011
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.10.011</ArticleId><ArticleId IdType="pubmed">27765603</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Qi Y, Fan H, Cui L, Shi Z. Systematic Identification and Bioinformatic Analysis of MicroRNAs in Response to Infections of Coxsackievirus A16 and Enterovirus 71. Biomed Res Int. 2016; 2016: 4302470
doi: 10.1155/2016/4302470
</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4302470</ArticleId><ArticleId IdType="pmc">PMC5098103</ArticleId><ArticleId IdType="pubmed">27843944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Wong KT. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses. Brain Pathol. 2015; 25: 614&#x2013;624. doi: 10.1111/bpa.12279
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12279</ArticleId><ArticleId IdType="pmc">PMC8029433</ArticleId><ArticleId IdType="pubmed">26276025</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010; 10: 778&#x2013;790. doi: 10.1016/S1473-3099(10)70194-8
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchette M, Daneman R. Formation and maintenance of the BBB. Mech Dev. 2015; 138 Pt 1: 8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">26215350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CY, Li JR, Chen WY, Ou YC, Lai CY, Hu YH, et al. Disruption of in vitro endothelial barrier integrity by Japanese encephalitis virus-Infected astrocytes. Glia. 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">25959931</ArticleId></ArticleIdList></Reference><Reference><Citation>Roe K, Orillo B, Verma S. West Nile virus-induced cell adhesion molecules on human brain microvascular endothelial cells regulate leukocyte adhesion and modulate permeability of the in vitro blood-brain barrier model. PLoS One. 2014; 9: e102598
doi: 10.1371/journal.pone.0102598
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102598</ArticleId><ArticleId IdType="pmc">PMC4103843</ArticleId><ArticleId IdType="pubmed">25036379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wang C, Shi T. Overview of available methods for diverse RNA-Seq data analyses. Sci China Life Sci. 2011; 54: 1121&#x2013;1128. doi: 10.1007/s11427-011-4255-x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-011-4255-x</ArticleId><ArticleId IdType="pubmed">22227904</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel RK, Jain M. NGS QC Toolkit: a toolkit for quality control of next generation sequencing data. PLoS One. 2012; 7: e30619
doi: 10.1371/journal.pone.0030619
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030619</ArticleId><ArticleId IdType="pmc">PMC3270013</ArticleId><ArticleId IdType="pubmed">22312429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013; 3: 71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4280562</ArticleId><ArticleId IdType="pubmed">25558171</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015; 4:e05005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4532895</ArticleId><ArticleId IdType="pubmed">26267216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015; 43: D146&#x2013;152. doi: 10.1093/nar/gku1104
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku1104</ArticleId><ArticleId IdType="pmc">PMC4383922</ArticleId><ArticleId IdType="pubmed">25378301</ArticleId></ArticleIdList></Reference><Reference><Citation>Auvinen E. Diagnostic and Prognostic Value of MicroRNA in Viral Diseases. Mol Diagn Ther. 2017; 21: 45&#x2013;57. doi: 10.1007/s40291-016-0236-x
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-016-0236-x</ArticleId><ArticleId IdType="pubmed">27682074</ArticleId></ArticleIdList></Reference><Reference><Citation>Meliopoulos VA, Andersen LE, Brooks P, Yan X, Bakre A, Coleman JK, et al.
MicroRNA regulation of human protease genes essential for influenza virus replication. PLoS One. 2012; 7: e37169
doi: 10.1371/journal.pone.0037169
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037169</ArticleId><ArticleId IdType="pmc">PMC3351457</ArticleId><ArticleId IdType="pubmed">22606348</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakre A, Mitchell P, Coleman JK, Jones LP, Saavedra G, Teng M, et al.
Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication. J Gen Virol. 2012; 93: 2346&#x2013;2356. doi: 10.1099/vir.0.044255-0
</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.044255-0</ArticleId><ArticleId IdType="pmc">PMC3542124</ArticleId><ArticleId IdType="pubmed">22894925</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L, Qi Y, Li H, Ge Y, Zhao K, Qi X, et al.
Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One. 2011; 6: e27071
doi: 10.1371/journal.pone.0027071
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027071</ArticleId><ArticleId IdType="pmc">PMC3210764</ArticleId><ArticleId IdType="pubmed">22087245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RY, Weng KF, Huang YC, Chen CJ. Elevated expression of circulating miR876-5p is a specific response to severe EV71 infections. Sci Rep. 2016; 6: 24149
doi: 10.1038/srep24149
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep24149</ArticleId><ArticleId IdType="pmc">PMC4823700</ArticleId><ArticleId IdType="pubmed">27052555</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Tien P. [MiR432* regulate the replication of coxsackievirus A16 in rhabdomyosarcoma cells]. Wei Sheng Wu Xue Bao. 2014; 54: 679&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">25272817</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui YL, Tan TL, Woo WH, Timms P, Hafner LM, Tan KH, et al.
Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS One. 2014; 9: e102997
doi: 10.1371/journal.pone.0102997
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0102997</ArticleId><ArticleId IdType="pmc">PMC4105423</ArticleId><ArticleId IdType="pubmed">25047717</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Zhang H, Su Y, Kong J, Yu H, Qian B. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers. Clin Transl Oncol. 2014; 16: 980&#x2013;985. doi: 10.1007/s12094-014-1183-9
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12094-014-1183-9</ArticleId><ArticleId IdType="pubmed">24805982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xu J, Ye J, Cheng X, Xie X, Lyu W. [Expression of miR-let-7e-3p in cervical intraepithelial neoplasm and cervix carcinoma and its clinical significance]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016; 45: 342&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10396891</ArticleId><ArticleId IdType="pubmed">27868406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai S, Ng KY, Tong M, Lau EY, Lee TK, Chan KW, et al.
Octamer 4/microRNA-1246 signaling axis drives Wnt/beta-catenin activation in liver cancer stem cells. Hepatology. 2016; 64: 2062&#x2013;2076. doi: 10.1002/hep.28821
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.28821</ArticleId><ArticleId IdType="pubmed">27639189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EK, et al.
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016; 7: 11702
doi: 10.1038/ncomms11702
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11702</ArticleId><ArticleId IdType="pmc">PMC4919505</ArticleId><ArticleId IdType="pubmed">27325363</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan D, Xu J, Wang J, Pan Y, Fu J, Bai Y, et al.
Extracellular miR-1246 promotes lung cancer cell proliferation and enhances radioresistance by directly targeting DR5. Oncotarget. 2016; 7: 32707&#x2013;32722. doi: 10.18632/oncotarget.9017
</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.9017</ArticleId><ArticleId IdType="pmc">PMC5078045</ArticleId><ArticleId IdType="pubmed">27129166</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakha S, Muramatsu T, Ueda K, Inazawa J. Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep. 2016; 6: 38750
doi: 10.1038/srep38750
</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep38750</ArticleId><ArticleId IdType="pmc">PMC5144099</ArticleId><ArticleId IdType="pubmed">27929118</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu LJ, Jiang T, Zhao W, Han JF, Liu J, Deng YQ, et al.
Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS One. 2014; 9: e95272
doi: 10.1371/journal.pone.0095272
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0095272</ArticleId><ArticleId IdType="pmc">PMC3989279</ArticleId><ArticleId IdType="pubmed">24739954</ArticleId></ArticleIdList></Reference><Reference><Citation>Xun M, Ma CF, Du QL, Ji YH, Xu JR. Differential expression of miRNAs in enterovirus 71-infected cells. Virol J. 2015; 12: 56
doi: 10.1186/s12985-015-0288-2
</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0288-2</ArticleId><ArticleId IdType="pmc">PMC4416288</ArticleId><ArticleId IdType="pubmed">25889836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathinayake PS, Hsu AC, Wark PA. Innate Immunity and Immune Evasion by Enterovirus 71. Viruses. 2015; 7: 6613&#x2013;6630. doi: 10.3390/v7122961
</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7122961</ArticleId><ArticleId IdType="pmc">PMC4690884</ArticleId><ArticleId IdType="pubmed">26694447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol. 2008; 18: 131&#x2013;140. doi: 10.1016/j.semcancer.2008.01.005
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2008.01.005</ArticleId><ArticleId IdType="pubmed">18291670</ArticleId></ArticleIdList></Reference><Reference><Citation>Monastyrskaya K, Sanchez-Freire V, Hashemi Gheinani A, Klumpp DJ, Babiychuk EB, Draeger A, et al.
miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol. 2013; 182: 431&#x2013;448. doi: 10.1016/j.ajpath.2012.10.020
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2012.10.020</ArticleId><ArticleId IdType="pubmed">23201090</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhou R, Zhang Z, Jin Y, Cardona CJ, Xing Z. Intrinsic apoptosis and proinflammatory cytokines regulated in human astrocytes infected with enterovirus 71. J Gen Virol. 2015; 96: 3010&#x2013;3022. doi: 10.1099/jgv.0.000235
</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000235</ArticleId><ArticleId IdType="pubmed">26296773</ArticleId></ArticleIdList></Reference><Reference><Citation>Velandia-Romero ML, Calderon-Pelaez MA, Castellanos JE. In Vitro Infection with Dengue Virus Induces Changes in the Structure and Function of the Mouse Brain Endothelium. PLoS One. 2016; 11: e0157786
doi: 10.1371/journal.pone.0157786
</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0157786</ArticleId><ArticleId IdType="pmc">PMC4919088</ArticleId><ArticleId IdType="pubmed">27336851</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>